Related Experiment Video
Updated: Jun 26, 2026

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
Published on: July 12, 2018
HAI-2 is epigenetically downregulated in human hepatocellular carcinoma, and its Kunitz domain type 1 is critical for
Edmund Kwok-Kwan Tung1, Chun-Ming Wong, Tai-On Yau
1Department of Pathology, Faculty of Medicine, Liver Cancer and Hepatitis Research Laboratory and S H Ho Foundation Research Laboratories, The University of Hong Kong, Pokfulam, Hong Kong.
Abstract:
Pharmacological demethylation-based gene expression profile analysis is a useful tool to identify epigenetically silenced tumour suppressor genes. HGF activator inhibitor 2 (HAI-2), a serine protease inhibitor, has been identified as one of the candidate tumour suppressor genes in human hepatocellular carcinoma (HCC) with this technique. In this study, we aimed to characterise the epigenetic status and tumour suppressive function of HAI-2 in HCC. We validated that HAI-2 expression was either absent or low in most of the HCC cell lines tested, and 5-Aza-2'-deoxycytidine treatment significantly restored its expression in 9 (75%) of these 12 cell lines. HAI-2 was found to be frequently underexpressed in human HCCs (p < 0.001). With bisulphite DNA sequencing and methylation-specific PCR, we found that the promoter of the HAI-2 gene was frequently hypermethylated in both HCC cell lines and human HCCs. Ectopic expression of HAI-2 significantly inhibited cell migration and invasiveness of HCC cells in vitro and suppressed tumourigenicity in vivo. In addition, we also provided the first evidence that HAI-2 mediated its tumour suppressor function via the Kunitz domain 1 (KD-1), as KD-1 but not KD-2 inactivating mutant abolished its anti-tumour invasiveness in vitro. Our findings suggest that HAI-2 is a candidate tumour suppressor gene that is frequently hypermethylated and underexpressed in human HCCs, and the KD-1 domain of HAI-2 is the key region responsible for its anti-invasive function.
Insights
Hepatocellular carcinoma (HCC) often shows low expression of HGF activator inhibitor 2 (HAI-2), a potential tumor suppressor. Promoter hypermethylation silences HAI-2, and restoring its expression inhibits HCC cell invasion and tumor growth, particularly via its KD-1 domain.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Pharmacological demethylation aids in identifying epigenetically silenced tumor suppressor genes.
- HGF activator inhibitor 2 (HAI-2) is a candidate tumor suppressor gene in human hepatocellular carcinoma (HCC).
Purpose of the Study:
- To characterize the epigenetic status and tumor suppressive function of HAI-2 in HCC.
- To investigate the role of HAI-2's Kunitz domains in its anti-tumor activity.
Main Methods:
- Gene expression analysis and pharmacological demethylation (5-Aza-2'-deoxycytidine).
- Bisulfite DNA sequencing and methylation-specific PCR to assess promoter methylation.
- In vitro cell migration/invasion assays and in vivo tumor xenograft models.
- Site-directed mutagenesis to inactivate Kunitz domains (KD-1, KD-2).
Main Results:
- HAI-2 expression was low/absent in HCC cell lines and human HCCs, frequently restored by demethylation.
- Frequent promoter hypermethylation of HAI-2 was observed in HCC.
- Ectopic HAI-2 expression inhibited HCC cell migration, invasion, and tumor growth.
- The KD-1 domain, but not KD-2, was essential for HAI-2's anti-invasive function.
Conclusions:
- HAI-2 is a frequently hypermethylated and underexpressed tumor suppressor gene in HCC.
- HAI-2 suppresses HCC cell invasiveness and tumorigenicity.
- The KD-1 domain is critical for HAI-2's anti-invasive tumor suppressor function.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
General Transcription Factors
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...

